Sanara Medtech IncNASDAQ:SMTI
- LAST PRICE37.7000
- TODAY'S CHANGE (%)0.3800 (1.0182%)
- Bid / Lots36.5500/ 1
- Ask / Lots42.0000/ 6
- Open / Previous Close38.0100 / 37.3200
- Day Range
- 52 Week Range
- Volume45,868
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMTI |
|---|---|---|
| 09:32 ET | 905 | 37.3 |
| 09:39 ET | 100 | 37.377236 |
| 10:02 ET | 100 | 37.5507 |
| 10:26 ET | 300 | 37.58 |
| 10:33 ET | 500 | 37.58 |
| 10:54 ET | 200 | 37.4 |
| 10:58 ET | 1000 | 37.98 |
| 11:16 ET | 250 | 37.75 |
| 11:18 ET | 839 | 37.65 |
| 11:21 ET | 200 | 37.83 |
| 11:23 ET | 535 | 37.65 |
| 11:34 ET | 184 | 37.694 |
| 11:36 ET | 4842 | 38 |
| 11:45 ET | 101 | 38.15 |
| 11:52 ET | 100 | 38.505 |
| 11:56 ET | 500 | 38.53 |
| 12:10 ET | 300 | 38.5 |
| 12:14 ET | 100 | 38.36 |
| 12:44 ET | 200 | 38.005 |
| 12:48 ET | 100 | 38.035 |
| 12:55 ET | 100 | 38.035 |
| 01:02 ET | 125 | 38.2703 |
| 01:40 ET | 200 | 37.82 |
| 01:56 ET | 250 | 38 |
| 01:58 ET | 565 | 37.75 |
| 02:03 ET | 325 | 38.0892 |
| 02:09 ET | 901 | 38.1 |
| 02:14 ET | 4412 | 38.15 |
| 02:27 ET | 1050 | 38.2 |
| 02:30 ET | 135 | 38.2999 |
| 02:34 ET | 193 | 38.065 |
| 02:38 ET | 100 | 37.96 |
| 02:41 ET | 100 | 37.96 |
| 02:48 ET | 100 | 37.76 |
| 03:17 ET | 535 | 37.9463 |
| 03:35 ET | 500 | 37.895 |
| 03:39 ET | 901 | 37.66 |
| 03:42 ET | 100 | 37.74 |
| 03:44 ET | 200 | 37.825 |
| 03:46 ET | 200 | 37.84 |
| 03:53 ET | 254 | 37.84 |
| 03:55 ET | 400 | 37.8 |
| 03:57 ET | 563 | 37.73 |
| 04:00 ET | 4129 | 37.7 |
Nov 12, 2024
*DJ Sanara MedTech 3Q Loss/Shr 34c >SMTI, from 4:27PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:27PM ET on Tuesday Nov 12, 2024 by Dow JonesSanara MedTech Inc. Reports Third Quarter 2024 Results, from 4:15PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:15PM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 31, 2024
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates, from 9:15AM ET on Thursday Oct 31, 2024 by Dow Jones
9:15AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sanara Medtech Inc | 326.4M | -38.2x | --- |
Daiichi Sankyo Co Ltd | 56.2B | 34.0x | --- |
Aquestive Therapeutics Inc | 411.2M | -10.1x | --- |
Theravance Biopharma Inc | 470.1M | -9.4x | --- |
Protalix Biotherapeutics Inc | 122.1M | -12.4x | --- |
OptiNose Inc | 59.6M | -2.2x | --- |
Company Information
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Contact Information
- Headquarters
- 1200 Summit Avenue, Suite 414FORT WORTH, TX, United States 76102
- Phone
- 817-529-2300
- Fax
- ---
Executives
- Executive Chairman of the Board, Chief Executive Officer
- Ronald Nixon
- Chief Financial Officer
- Michael McNeil
- Chief Operating Officer
- Jacob Waldrop
- Director
- Keith Myers
- Director
- Ann Salamone
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $326.4M |
|---|---|
Revenue (TTM) | $78.1M |
Shares Outstanding | 8.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.58 |
EPS | $-0.99 |
Book Value | $5.25 |
P/E Ratio | -38.2x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
